A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Clinical trial NCT07049055 · RECRUITING

Trial details

NCT number: NCT07049055
Sponsor: Engeneic Pty Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer, Metastatic PDAC - Pancreatic Ductal Adenocarcinoma

Start date: 2026-01-12
Primary completion: 2028-09-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.